为了获得访问"阿拉丁铁蛋"实时聊天框的流畅支持体验，建议您使用Chrome浏览器或选择360浏览器极速模式(如何切换极速模式?)，感谢您选择我们！
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| rp174314-500μg |
500μg |
期货  |
| |
| rp174314-1mg |
1mg |
期货 |
|
| 产品名称 | IL-6 |
|---|---|
| 别名 | B-cell stimulatory factor 2;CTL differentiation factor;hybridoma growth factor;interferon β2;interleukin-6 |
| 英文别名 | B-cell stimulatory factor 2;CTL differentiation factor;hybridoma growth factor;interferon β2;interleukin-6 |
| CAS编号和信息 | rp174314 |
|---|
| UniProtKB | P05231 |
|---|---|
| Wikipedia | Interleukin_6 |
| RCSB PDB Structure | 1ALU |
| Protein GI | 51095021 |
| Immunopaedia Search | IL-6 |
| Ensembl Gene | ENSG00000136244 |
输入批号以搜索COA:
| 1. Morjaria JB, Babu KS, Vijayanand P, Chauhan AJ, Davies DE, Holgate ST. (2011) Sputum IL-6 concentrations in severe asthma and its relationship with FEV1.. Thorax, 66 (6): (537). [PMID:20880874] |
| 2. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. (2011) The pro- and anti-inflammatory properties of the cytokine interleukin-6.. Biochim Biophys Acta, 1813 (5): (878-88). [PMID:21296109] |
| 3. Ferreira MA, Matheson MC, Duffy DL, Marks GB, Hui J, Le Souëf P, Danoy P, Baltic S, Nyholt DR, Jenkins M et al.. (2011) Identification of IL6R and chromosome 11q13.5 as risk loci for asthma.. Lancet, 378 (9795): (1006-14). [PMID:21907864] |
| 4. Uddin M, Lau LC, Seumois G, Vijayanand P, Staples KJ, Bagmane D, Cornelius V, Dorinsky P, Davies DE, Djukanović R. (2013) EGF-induced bronchial epithelial cells drive neutrophil chemotactic and anti-apoptotic activity in asthma.. PLoS ONE, 8 (9): (e72502). [PMID:24039773] |
| 5. Genovese MC, Fleischmann R, Furst D, Janssen N, Carter J, Dasgupta B, Bryson J, Duncan B, Zhu W, Pitzalis C et al.. (2014) Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study.. Ann Rheum Dis, 73 (9): (1607-15). [PMID:24641941] |
| 6. Engler H, Brendt P, Wischermann J, Wegner A, Röhling R, Schoemberg T, Meyer U, Gold R, Peters J, Benson S et al.. (2017) Selective increase of cerebrospinal fluid IL-6 during experimental systemic inflammation in humans: association with depressive symptoms.. Mol Psychiatry, 22 (10): (1448-1454). [PMID:28138158] |
| 7. Takeuchi T, Tanaka Y, Yamanaka H, Amano K, Nagamine R, Park W, Shiozawa K, Tsukano M, Wei JC, Shao J et al.. (2016) Efficacy and safety of olokizumab in Asian patients with moderate-to-severe rheumatoid arthritis, previously exposed to anti-TNF therapy: Results from a randomized phase II trial.. Mod Rheumatol, 26 (1): (15-23). [PMID:26358841] |
| 8. Sun Y, Wang D, Salvadore G, Hsu B, Curran M, Casper C, Vermeulen J, Kent JM, Singh J, Drevets WC et al.. (2017) The effects of interleukin-6 neutralizing antibodies on symptoms of depressed mood and anhedonia in patients with rheumatoid arthritis and multicentric Castleman's disease.. Brain Behav Immun, 66 (13): (156-164). [PMID:28676350] |
| 9. Garbers C, Heink S, Korn T, Rose-John S. (2018) Interleukin-6: designing specific therapeutics for a complex cytokine.. Nat Rev Drug Discov, 17 (6): (395-412). [PMID:29725131] |
| 10. Bhaskar S, Sinha A, Banach M, Mittoo S, Weissert R, Kass JS, Rajagopal S, Pai AR, Kutty S. (2020) Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper.. Front Immunol, 11 (13): (1648). [PMID:32754159] |
| 11. Hu B, Huang S, Yin L. (2021) The cytokine storm and COVID-19.. J Med Virol, 93 (1): (250-256). [PMID:32592501] |
| 12. Yokoyama A, Kohno N, Fujino S, Hamada H, Inoue Y, Fujioka S, Ishida S, Hiwada K. (1995) Circulating interleukin-6 levels in patients with bronchial asthma.. Am J Respir Crit Care Med, 151 (5): (1354-8). [PMID:7735584] |
| 13. Shaw S, Bourne T, Meier C, Carrington B, Gelinas R, Henry A, Popplewell A, Adams R, Baker T, Rapecki S et al.. (2014) Discovery and characterization of olokizumab: a humanized antibody targeting interleukin-6 and neutralizing gp130-signaling.. MAbs, 6 (3): (774-82). [PMID:24670876] |
首页
400-620-6333
危险品化学品经营许可证（带存储）